Lung Injury in COVID-19 Has Pulmonary Edema as an Important Component and Treatment with Furosemide and Negative Fluid Balance (NEGBAL) Decreases Mortality
The SARS-CoV2 promotes dysregulation of Renin–Angiotensin–Aldosterone. The result is excessive retention of water, producing a state of noxious hypervolemia. Consequently, in COVID-19 injury lung is pulmonary edema. Our report is a case–control study, retrospective. We included 116 patients with mod...
Main Authors: | Jose L. Francisco Santos, Patricio Zanardi, Veronica Alo, Vanina Dos Santos, Leonardo Bovone, Marcelo Rodriguez, Federico Magdaleno, Virginia De Langhe, Andrea Villoldo, Romina Martinez Souvielle, Julieta Alconcher, Diego Quiros, Claudio Milicchio, Eduardo Garcia Saiz |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-02-01
|
Series: | Journal of Clinical Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2077-0383/12/4/1542 |
Similar Items
-
Pulmonary Edema in COVID-19 Treated with Furosemide and Negative Fluid Balance (NEGBAL): A Different and Promising Approach
by: Jose L. Francisco Santos, et al.
Published: (2021-11-01) -
Administration of Intravenous Furosemide in Patients with Acute Infection: Patient Characteristics and Impact on In-Hospital Outcome
by: Nir Levi, et al.
Published: (2023-05-01) -
Oral Furosemide and Hydrochlorothiazide/Amiloride versus Intravenous Furosemide for the Treatment of Resistant Nephrotic Syndrome
by: Georgiana Frățilă, et al.
Published: (2023-11-01) -
Furosemide and spironolactone doses and hyponatremia in patients with heart failure
by: Ivan Velat, et al.
Published: (2020-08-01) -
Enhanced diuretic action of furosemide by complexation with β-cyclodextrin in the presence of sodium lauryl sulfate
by: Al-Shdefat Ramadan I.
Published: (2020-12-01)